Allos Therapeutics, Inc., is a biopharmaceutical company that develops drugs for the treatment of cancer. Allos Therapeutics reported the following financial data (in thousands) for the years ending December 31, 2008, 2007, and 2006.

a. Determine the monthly cash expenses for 2008, 2007, and 2006. Round to one decimal place.b. Determine the ratio of cash to monthly cash expenses as of December 31, 2008, 2007, and 2006. Round to one decimal place.c. Based on (a) and (b), comment on Allos Therapeutics ratio of cash to monthly operating expenses for 2008, 2007, and2006.

For Years Ending December 31 2008 2008 2007 Cash and cash equivalents $ 30,696 (42,850) $ 16,103 (30,825) $ 10,437 (25,147) Net cash flows from operations